March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Evaluation Of Commercially Available Novel Multipurpose Contact Lens Care Solutions Effect On Membrane-associated Mucin Expression In The Rat Cornea
Author Affiliations & Notes
  • Kissaou T. Tchedre
    R & D and Innovation Center, Menicon LTD, Kasugai, Japan
  • Masaki Imayasu
    R & D and Innovation Center, Menicon LTD, Kasugai, Japan
  • Yuichi Hori
    Ophthalmology, Toho University Sakura Medical Center, Sakura, Japan
  • H D. Cavanagh
    Ophthalmology, Univ Texas Southwestern Med Ctr, Dallas, Texas
  • Footnotes
    Commercial Relationships  Kissaou T. Tchedre, Menicon (E); Masaki Imayasu, Menicon (E); Yuichi Hori, None; H. D. Cavanagh, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 6078. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Kissaou T. Tchedre, Masaki Imayasu, Yuichi Hori, H D. Cavanagh; Evaluation Of Commercially Available Novel Multipurpose Contact Lens Care Solutions Effect On Membrane-associated Mucin Expression In The Rat Cornea. Invest. Ophthalmol. Vis. Sci. 2012;53(14):6078.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : The purpose of this study is to determine whether commercially available new multipurpose contact lens care solutions (MPSs) have any effect on membrane-associated mucins (Muc1 & 16) expressions in the cornea using SV40 transformed Human corneal epithelial Cells (HCET) and Rat cornea. Membrane-associated mucins are one of the major components of the ocular surface that play a vital role in the maintenance of the ocular surface integrity.

Methods: : Human corneal epithelial cells were treated with different concentrations of MPS-F (1ppm PHMB, no boric acid), MPS-G (1.3ppm PHMB, 1ppm PQ-1, boric acid), MPS-H (1.6 ppm, Alexidine, 3ppm PQ-1, boric acid), MPS-I (1ppm PHMB, boric acid), and MPS-J (5ppm ALDOX, 10ppm PQ-1, boric acid): 100% treatment for 30 minutes and 10% treatment for 24 hours. Membrane-associated mucins (Muc 1 and Muc 16) expressions were subsequently analyzed by Western blot. Winstar Rats were also subjected to MPSs (1 drop in the right eye every 10 minutes for 1 hour). The left Eye was used as control (1 drop of PBS every 10 min for 1 hour). Cornea lysates were subsequently prepared and used for western blot analysis.

Results: : Western blot results showed that MPSs containing boric acid down-regulate membrane-associated mucins in the cornea while MPSs without boric acid had no effect on membrane-associated mucins.

Conclusions: : Boric acid used in commercially available multipurpose contact lens care solutions as a buffer concentration should be chosen carefully to avoid MPS-related ocular surface damage. Ocular surface damage simultaneously promotes microbial pathogens and potentially increases clinical rates of infection.

Keywords: cornea: epithelium • cornea: surface mucins • cornea: basic science 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×